These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11139130)

  • 1. Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery.
    Flatt PM; Pietenpol JA
    Drug Metab Rev; 2000; 32(3-4):283-305. PubMed ID: 11139130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle checkpoints as therapeutic targets.
    Stewart ZA; Pietenpol JA
    J Mammary Gland Biol Neoplasia; 1999 Oct; 4(4):389-400. PubMed ID: 10705922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
    Pietenpol JA; Stewart ZA
    Toxicology; 2002 Dec; 181-182():475-81. PubMed ID: 12505356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-cycle checkpoint kinases: checking in on the cell cycle.
    Walworth NC
    Curr Opin Cell Biol; 2000 Dec; 12(6):697-704. PubMed ID: 11063934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ensuring the stability of the genome: DNA damage checkpoints.
    Latif C; Harvey SH; O'Connell MJ
    ScientificWorldJournal; 2001 Nov; 1():684-702. PubMed ID: 12805771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular anatomy of the DNA damage and replication checkpoints.
    Qin J; Li L
    Radiat Res; 2003 Feb; 159(2):139-48. PubMed ID: 12537518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of apoptosis signaling pathways and cell cycle regulation.
    Eastman A; Rigas JR
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):7-16; discussion 41-2. PubMed ID: 10585003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle checkpoints and their impact on anticancer therapeutic strategies.
    Eastman A
    J Cell Biochem; 2004 Feb; 91(2):223-31. PubMed ID: 14743382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage checkpoints in mammals.
    Niida H; Nakanishi M
    Mutagenesis; 2006 Jan; 21(1):3-9. PubMed ID: 16314342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 tumor suppressor participates in multiple cell cycle checkpoints.
    Giono LE; Manfredi JJ
    J Cell Physiol; 2006 Oct; 209(1):13-20. PubMed ID: 16741928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of the cell cycle and the development of cancer: therapeutic prospects].
    Peralta-Zaragoza O; Bahena-Román M; Díaz-Benítez CE; Madrid-Marina V
    Salud Publica Mex; 1997; 39(5):451-62. PubMed ID: 9424727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage-dependent cell cycle checkpoints and genomic stability.
    Ishikawa K; Ishii H; Saito T
    DNA Cell Biol; 2006 Jul; 25(7):406-11. PubMed ID: 16848682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle control and cancer.
    Hartwell LH; Kastan MB
    Science; 1994 Dec; 266(5192):1821-8. PubMed ID: 7997877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases.
    Golubnitschaja O
    Amino Acids; 2007; 32(3):359-71. PubMed ID: 17136506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cell cycle in mediating sensitivity to radiotherapy.
    Pawlik TM; Keyomarsi K
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):928-42. PubMed ID: 15234026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models.
    Zuco V; Supino R; De Cesare M; Carenini N; Perego P; Gatti L; Pratesi G; Pisano C; Martinelli R; Bucci F; Zanier R; Carminati P; Zunino F
    Biochem Pharmacol; 2003 Apr; 65(8):1281-94. PubMed ID: 12694869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting checkpoint kinase 1 in cancer therapeutics.
    Tse AN; Carvajal R; Schwartz GK
    Clin Cancer Res; 2007 Apr; 13(7):1955-60. PubMed ID: 17404075
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Ezerskyte M; Paredes JA; Malvezzi S; Burns JA; Margison GP; Olsson M; Scicchitano DA; Dreij K
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4731-4736. PubMed ID: 29666243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.